Is Rejuran worth it in Seoul? What to know before you book
“Everyone says I have to try Rejuran in Korea. Is it really that good?” “Do I get it once, or do I need to come back?” These are the two questions we hear most from people planning a Seoul beauty trip. The short answer: Rejuran is not a one-visit transformation. It works more like a short course that gradually refines texture and fine lines, which means fitting it around your travel dates matters as much as the treatment itself. Here is what the research and Korean clinic practice actually show.
COMEDI editorial draft · 2026-09-28 · Not clinically reviewed
1. What kind of treatment is Rejuran?
Rejuran is a Korean skin booster: a DNA-derived ingredient from salmon (polynucleotides) injected into the upper layer of the skin. Unlike filler, it doesn’t add volume. It aims to improve the skin itself, its texture, fine lines and elasticity.
That also tells you when it’s the wrong tool. If what bothers you is hollow cheeks or a jawline that has dropped, Rejuran is unlikely to be the answer. Sorting your concern into “skin quality” or “volume and lift” before the consultation makes the conversation far more useful.
2. What changes have studies reported?
Across the published studies, the consistent finding is improvement in fine lines, texture and elasticity. A 2024 systematic review pulled together nine studies of this type of injection, covering 219 people, and several reported better wrinkles, texture and firmness. Seven of the nine were carried out in Korea.
A 2026 study followed 42 people who had under-eye injections of the same type for six months. Satisfaction peaked about three months after two sessions and eased slightly by six months. That study used a different brand, not Rejuran.
*Based on published research. Results and recovery vary from person to person.
3. The evidence is still small
To be candid, the evidence behind Rejuran is not as solid as its popularity suggests. The 2024 review rated its own studies as low to moderate quality and concluded that more rigorous research is needed.
There is also a detail most articles skip. The 2014 Korean trial that compared this type of injection directly with hyaluronic acid filler was retracted in 2016 for failing to disclose manufacturer funding, yet the review still counts it. Another paper the review cites was retracted in 2024 over its photographs.
None of this means Rejuran doesn’t work. It means claims like “better than filler” or “guaranteed regeneration” are running ahead of the evidence.
4. How many sessions, and how far apart?
Korean dermatologists most often recommend three sessions, four weeks apart. In a 2023 survey of 235 Korean board-certified dermatologists, 88% said they use this type of injection, and “three sessions, four weeks apart” was the most common schedule.
Roughly eight in ten (79%) also combine it with device treatments such as radiofrequency or ultrasound lifting (HIFU). When you compare quotes, check whether you are looking at Rejuran alone or a bundled package.
*Based on published research. Results and recovery vary from person to person.
5. Planning it around a short trip
If you are in Seoul for about a week, you won’t finish a full course in one trip. That usually leaves three options: have the first session in Seoul and continue at home, return to Seoul a few weeks later, or have a single session and see how your skin responds. Which one suits you depends on your skin and your calendar, so ask before you lock in flights.
Also keep in mind that the change is usually clearest after you are home. Decide in advance how you will take comparison photos and who you will contact if a question comes up.
6. Questions worth bringing to the consultation
Consultations are often shorter than people expect, so it helps to arrive with questions written down. Ask whether the product and amount match your quote, how many sessions are recommended for your skin, and whether the price includes numbing, any device treatment and a follow-up visit. Find out which reactions are normal in the first few days and when you should get in touch.
Because the ingredient comes from salmon, mention any fish allergy at the start. COMEDI helps you organise these questions and compare quotes on the same terms; whether to go ahead is decided with the clinician who examines you.
7. The bottom line
Rejuran is worth considering if your goal is gradually refining texture and fine lines. It isn’t a one-visit treatment, and its evidence is still growing, so set your expectations at natural change rather than a dramatic one. Rather than squeezing sessions into a holiday, start with a plan that your actual schedule can support.
FAQ: Does one Rejuran session make a difference?
Some people notice a change after one Rejuran session, but the schedule Korean dermatologists recommend most is three sessions four weeks apart. In the under-eye study, satisfaction was highest after the second session. If one visit is all you can manage, say so at the start of the consultation.
FAQ: Does Rejuran hurt, and will I swell?
Rejuran can leave the injection area swollen, red, sore or itchy for a short time. In the studies collected by the 2024 review, these reactions usually settled within a week, and no serious side effects were reported. The studies were small, though, so rarer problems can’t be ruled out.
FAQ: Is Rejuran safer than filler?
There isn’t enough evidence to say Rejuran is safer than filler. The main trial comparing the two was retracted. They also solve different problems, so the better first question is which one fits your concern.
EVIDENCE / SCOPE & LIMITS
Papers, and what they can tell us
Original sources checked for the claims used here. This is not a comprehensive systematic search or independent clinical review. Reading coverage is disclosed for each paper.
[S1] Lampridou S, Bassett S, Cavallini M, Christopoulos G. The Effectiveness of Polynucleotides in Esthetic Medicine: A Systematic Review. J Cosmet Dermatol. 2024;24(2):e16721. ↗
2024 · DOI: 10.1111/jocd.16721
Systematic review; 9 studies, 219 patients, 7 of 9 in Korea; quality rated low to moderate; no meta-analysis. Includes a study later retracted (S2) and cites a retracted paper (S3). Authors disclose ties to the manufacturer Mastelli and a distributor. PARTIAL review: abstract, methods, included-study table, results, adverse events, limitations, conflicts and reference list; supplementary tables not audited.
[S2] Notice of Retraction: Pak CS et al., Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow's Feet. J Korean Med Sci. 2016;31(2):330. ↗
2016
Retraction notice. The publication board concluded the 2014 article misreported its conflict of interest and funding sponsor; the trial was funded by the filler's manufacturer and a co-author was a company researcher. FULL reading of the notice; the retracted trial itself was not re-analysed.
[S3] Retraction: Cavallini M et al., PN-HPT in facial middle third rejuvenation. J Cosmet Dermatol. 2024. ↗
2024
Retracted by the journal and publisher after unresolved concerns about duplicated before-and-after images in one figure; conclusions no longer considered reliable. FULL reading of the notice. Cited in S1's discussion; not one of its nine included studies.
[S4] A survey on the cosmetic use of injectable polynucleotide: The pattern of practice among Korean dermatologists. J Cosmet Dermatol. 2024;23(4):1243-1252 (online 2023). ↗
2023 · DOI: 10.1111/jocd.16125
Survey of 235 Korean board-certified dermatologists: 88% use PN; top indications fine lines on cheek and around the eyes; three sessions four weeks apart most often recommended; 79% combine with energy devices. Describes practice, not efficacy. ABSTRACT_ONLY.
[S5] Prospective Observational Study of Polynucleotide Injections for Periorbital Rhytides. J Cosmet Dermatol. 2026;25(2):e70736. ↗
2026 · DOI: 10.1111/jocd.70736
Single-clinic observational case series, 42 patients, no control group, product Pluryal Silk 7.5 mg/mL (not Rejuran). Patient-reported outcomes peaked at 3 months after two sessions, eased by 6 months; improvement began after the first session; minimal adverse events; authors declare no conflicts. PARTIAL review.
General planning and style information, not diagnosis, personalised treatment advice or a promise of results. Clinical questions require a qualified clinician. Cultural interpretation is not evidence about personality or the future.
